Welcome to PakSearch.com Pakistan's Premier Business Information
Service


For business information, annual reports, laws, ordinances, regulations and articles.




Google
 
Web Paksearch.com
RECKITT & COLMAN PAKISTAN
ANNUAL REPORT 1997
CONTENTS
Notice of Meeting
Review of the Year
Comparison of Results
Report of the Directors
Auditors' Report to the Members
Profit and Loss Account
Balance Sheet
Cash Flow Statement
Notes to the Accounts
Pattern of Shareholding
List of Products
COMPANY INFORMATION
BOARD OF DIRECTORS
K.J. Dinshaw Chairman
Tariq Ikram Chief Executive
J.C.L. de Mel (Alternate:
Ishtiaqur Rehman)
M.F. Turrell (Alternate:
Isar Ahmad)
M. Waddington
Rasheed Y. Chinoy
Razi-ur-Rahman Khan (NIT)
Yusuf G. Mandviwalla
SECRETARY
N.H. Haqqi
BANKERS
ANZ Grindlays Bank
Citibank
Standard Chartered Bank
Muslim Commercial Bank
Prime Commercial Bank
AUDITORS
A.F. Ferguson & Co.
SOLICITORS
Surridge & Beecheno
REGISTRARS
Ferguson Associates (Pvt) Ltd.
State Life Building 1-A
I.I. Chundrigar Road
P.O. Box 4716
Karachi 74000.
Tel: 2426682-6, 2426711-5
NOTICE OF MEETING
Notice is hereby given that the Forty-Seventh Annual General Meeting of the Company will be held at 10:00
a.m. on Wednesday, 22 April, 1998 at the Avari Towers, Fatima Jinnah Road, Karachi, to transact the
following business:
1. To receive and consider the Statement of Accounts for the fifty-two week financial period ended
January 3, 1998 and the Reports of the Directors and Auditors thereon.
2. To declare a final dividend.
3. To appoint auditors and to fix their remuneration.
NOTES:
i. The Share Transfer Books of the Company will be closed from April 13, 1998 to April 22, 1998 both
days inclusive.
ii. A Member entitled to attend the Annual General Meeting is entitled to appoint a proxy to attend and
vote instead of him/her. No person shall act as a proxy (except for a corporation) unless he/she is entitled
to be present and vote in his/her own right. The completed proxy form must be received at the Registered
Office Of the Company not less than 48 hours before the Meeting.
iii. Shareholders are requested to immediately notify the Company of any change of address.
REVIEW OF THE YEAR
Trading Performance
Despite a general sluggishness in the market place, the Company has fared relatively well in the year under
report. A number of non-performing products were discontinued and this has helped focus on the core lines
to which strong and selective pricing and marketing policies and new innovative selling pressures have been
applied. Also, this was the first full year with us of the household insecticide business which was acquired from
AgrEvo end 1996, the performance of which has been most encouraging.
Company sales have grown 27.9%, the Pharma segment being the larger contributor. Gross Margin too has
improved (30% as against 29.2% in 1996) helped by inventories carried at pre-devaluation and pre-duty-
increase rates. With the Selling and Administration ratio contained at 15.0% (1996: 16.3%) the Operating
Profit of Rs.295.279 mn. for the year is an improvement of Rs. 97.990 mn. over 1996.
The higher level generally of working assets this year combined with the impact of the AgrEvo acquisition
cost has exerted pressure on cash leading to a net increase in financial costs. Taxation was extraordinarily low
in 1996 due reversal of prior years' provisions, whereas this phenomenon has had a much lower bearing in
1997. Accordingly, the improvement in Operating Profit has been erased at Profit after Taxation level, which
latter is Rs. 197.727 mn as against Rs. 197.962 mn. in the previous year.
Appropriations
The Board recommends:
- a final dividend of Rs. 76.940 mn.[ @ Rs.2.40 per share] which together with the interim ofrs.35.265
mn. makes a total of Rs. 112.205 mn. [ 1996: Rs. 112.205mn.].
- the transfer of Rs. 85 mn. to General Reserve [ 1996:Rs.85 mn.].
Prospects and Development
The full impact of the withdrawal of exemption from duty on certain raw materials for our largest
pharmaceutical products category will be felt in 1998. Besides, the Governments indefinite withholding of
price increases on pharma products, now already four months overdue, is cause for much concern.
A development which could impact the business adversely is the alliance which Reckitt & Colman plc, U.K.
has entered into with Schering-Plough under which Schering has been given the rights to market and distribute
Reckitts' buprenorphine product under the TEMGESIC brand. Schering has not yet announced what their
plans for Pakistan are and until then we will continue to import, promote and sell this product.
Another growing concern is the spread across the country of low priced but very cheap quality paste shoe
polish which is being smuggled in mainly via the Afghan transit trade facility. The large extent of this product' s
availability is an indication of the well organised network for its procurement, import and subsequent
distribution within Pakistan. The Government has been apprised of the significant loss of revenue due to the
sale of smuggled polish and the Company will step up further its efforts to convince the concerned officials
upto the highest level to take appropriate measures.
Despite the factors enumerated above, the Company is confident in the ability of its team to face challenges
and will intensify its efforts to grow the business through maintaining high product quality standards, by
aggressive and skillful marketing and selling, and through cost containment.
Directors
There was no change in the constitution of the Board during the year under report.
COMPARISON OF RESULTS
1991 1992 1993 1994 1995 1996 1997
     (Rupees '000)
EARNINGS & DISTRIBUTION (RECKITT & COLMAN OF PAKISTAN LTD.)
Sales 498,526 602,149 741,278 792,200 922,447 1,534,110 1,962,397
Profit before tax 93,519 110,070 118,183 123,104 157,839 199,416 253,555
Taxes 41,731 53,751 43,016 46,594 52,556 1,454 55,828
Net earnings 51,788 56,319 75,167 76,510 105,283 197,962 197,727
Dividend 29,409 35,290 41,172 45,172 59,288 112,205 112,205
Retained in business 22,379 21,029 33,995 31,338 45,995 85,757 85,522
Bonus shares issued 10,892 19,606 0 23,527 28,232 49,368 0
EARNINGS & DISTRIBUTION (FORMER RECKITT & COLMAN PHARMACEUTICALS (PVT.) LTD.)
Sales 200,726 249,239 293,985 373,284 417,200
Profit before tax 38,672 47,404 75,222 105,698 110,756
Taxes 20,937 24,679 37,155 47,864 22,025
Net earnings 17,735 22,725 38,067 57,834 88,731
Dividend 8,655 10,230 12,835 17,113 20,964
Retained in business 9,080 12,495 25,232 40,721 67,767
Bonus shares issued 5,167 5,167 4,651 7,130 17,114
FINANCIAL POSITION (RECKITT & COl. MAN OF PAKISTAN LTD.)
Share Capital 98,029 117,635 117,635 141,162 169,394 320,587 320,587
Capital and revenue reserves  78,678 80,101 114,096 121,907 137,128 282,633 368,155
Shareholders equity 176,707 197,736 231,731 263,069 306,522 603,220 688,742
Surplus on revaluation 671 671 671 671 671 1,408 1,408
Long term loans and deferred liabilities/tax 18,435 22,240 20,642 27,438 33,421 54,787 64,136
Total capital employed 195,813 220,647 253,044 291,178 340,614 659,415 754,286
Represented by:
Fixed assets 53,132 62,228 101,578 128,083 151,738 327,147 345,796
Long-term loans/deposits & deferred cost 1,209 944 2,511 4,779 3,964 39,798 34,515
Net current assets 141,472 157,475 148,955 158,316 184,912 292,470 373,975
STATISTICS (RECKITT & COLMAN OF PAKISTAN LTD.)
Net earnings per share (Rs.) 5.28 4.79 6.39 5.42 6.22 6.17 6.17
Dividend declared per share (Rs.) 3.00 3.00 3.50 3.20 3.50 3.50 3.50
Bonus issue 2:10 0 2:10 2:10 3:20 0 0
Break up value per share (Rs.) 18.03 16.81 19.70 18.64 18.10 18.82 21.48
* COMBINED RESULTS INCLUDING THE FORMER RECKITT & COLMAN PHARMACEUTICALS (PVT.) LTD.
REPORT OF THE DIRECTORS
The Directors submit their Report together with the audited Statement of Accounts for the fifty-two week
financial period ended January 3, 1998.
Business Review
The annexed Review deals with the year's activities and the Directors of the Company endorse the contents
thereof.
Financial Results and Appropriations
The profit and appropriations are as follows:
Rupees'000
Net profit for the year before tax 253,555
Less: Provision for tax 55,828
----------
Profit after tax 197,727
Unappropriated profit from previous year 5,333
----------
Profit available for appropriation 203,060
Appropriations:
35,265
76,940
Transfer to General Reserve 85,000 197,205
---------- ----------
Unappropriated profit carried forward to next year 5,855
==========
Earnings per share
The "earnings per share" numbers are provided at page 4.
Pattern of Shareholding
The pattern of shareholding is provided at page 31. The Company's holding company is Reckitt & Colman
plc, which is incorporated in the U.K.
Directors
Directors were last elected for a period of three years at the Annual General Meeting held on March 28, 1996.
Auditors
The Company's auditors Messrs. A.F. Ferguson & Co., retire and offer themselves for re-appointment.
AUDITORS' REPORT TO THE MEMBERS
We have audited the annexed balance sheet of Reckitt & Colman of Pakistan Limited as at January 3, 1998
and the related profit and loss account and cash flow statement, together with the notes forming part thereof,
for the fifty two weeks then ended and we state that we have obtained all the information and explanations
which to the best of our knowledge and belief were necessary for the purposes of our audit and, after due
verification thereof, we report that:
(a) in our opinion, proper books of account have been kept by the company as required by the Companies
Ordinance, 1984;
(b) in our opinion:
(i) the balance sheet and profit and loss account together with the notes thereon have been drawn up
in conformity with the Companies Ordinance, 1984 and are in agreement with the books of
account and are further in accordance with accounting policies consistently applied;
(ii) the expenditure incurred during the period was for the purpose of the company's business; and
(iii) the business conducted, investments made and the expenditure incurred during the period were
in accordance with the objects of the company;
(c) in our opinion and to the best of our information and according to the explanations given to us, the
balance sheet, profit and loss account and the cash flow statement, together with the notes forming part
thereof, give the information required by the Companies Ordinance, 1984 in the manner so required and
respectively give a true and fair view of the state of the company's affairs as at January 3, 1998 and of
the profit and cash flows for the fifty two weeks then ended; and
(d) in our opinion Zakat deductible at source under the Zakat and Ushr Ordinance, 1980 was deducted by
the company and deposited in the Central Zakat Fund established under Section 7of that Ordinance.
A.F. Ferguson & Co.
Chartered Accountants
PROFIT AND LOSS ACCOUNT FOR THE 52 WEEKS ENDED JANUARY 3, 1998
Note 52 weeks 53 weeks
ended January ended January
3, 1998 4, 1997
(Rupees in thousand)
Sales 3 1,962,397 1,534,110
Cost of sales 3 1,373,083 1,086,017
---------- ----------
589,314 448,093
Selling and administrative expenses 3 294,035 250,804
---------- ----------
Operating profit 3 295,279 197,289
Other income 6 10,585 29,886
---------- ----------
305,864 227,175
---------- ----------
Financial expenses 7 18,759 9.48
Other charges 8 33,550 18,279
---------- ----------
52,309 27,759
---------- ----------
Profit before taxation 253,555 199,416
Taxation 9 55,828 1,454
---------- ----------
Profit after taxation 197,727 197,962
Unappropriated profit brought forward 5,333 4,576
---------- ----------
Profit available for appropriation 203,060 202,538
Appropriations
Transfer to general reserve 85,000 850,001
Interim dividend 10 35,265 41,676
Proposed final dividend 10 76,940 70,529
---------- ----------
197,205 197,205
---------- ----------
Unappropriated profit carried forward 5,855 5,333
========== ==========
The annexed notes form an integral part of these accounts.
BALANCE SHEET AS AT 3, JANUARY 1998
Note As at As at
January January
3, 1998 4, 1997
(Rupees in thousand)
SHARE CAPITAL AND RESERVES
Share capital
Authorised
50,000,000 ordinary shares of Rs. 10 each 500,000 500,000
========== ==========
Issued, subscribed and paid-up 11 320,587 320,587
Reserves 12 362,300 277,300
Unappropriated profit 5,855 5,333
---------- ----------
688,742 603,220
SURPLUS ON REVALUATION OF FIXED ASSETS 13 1,408 1,408
LONG-TERM LOANS - 766
DEFERRED LIABILITY - Staff Gratuity 14 75,850 62,063
CURRENT LIABILITIES ---------- ----------
Short-term finance under mark-up arrangements 15 1,116 48,789
Creditors, accured and other liabilities 16 317,572 241,877
Taxation 9 2,564 16,646
Dividends 17 78,589 71,912
---------- ----------
399,841 379,224
CONTINGENCIES AND COMMITMENTS 18
---------- ----------
1,165,841 1,046,681
========== ==========
FIXED ASSETS
- Tangible
Operating assets 19 298,088 294,960
Capital work-in-progress - at cost 20 35,708 17,187
- Intangible
Goodwill 21 12,000 15,000
---------- ----------
345,796 327,147
DEFERRED COST 22 24,000 30,000
DEFERRED TAXATION 23 1,714 8,042
LONG-TERM LOANS 24 5,439 4,042
LONG-TERM DEPOSITS AND PREPAYMENTS 25 5,076 5,756
CURRENT ASSETS ---------- ----------
Stores, spares and loose tools 26 4,580 8,212
Stock-in-trade 27 242,045 280,126
Trade debts 28 454,789 205,710
Current portion of long-term loans 1,686 1,197
Advances 29 8,839 22,824
Deposits and short-term prepayments 30 11,116 13,089
Other receivables 31 30,893 54,141
Short-term investment 32 2,000 77,000
Cash and bank balances 33 17,868 9,395
---------- ----------
773,816 671,694
---------- ----------
1,165,841 1,046,681
========== ==========
The annexed notes form an integral part of these accounts.
CASH FLOW STATEMENT FOR THE 52 WEEKS ENDED JANUARY 3, 1998
Note 52 weeks 53 weeks
ended January ended January
3, 1998 4, 1997
(Rupees in thousand)
CASH FLOW FROM OPERATING ACTIVITIES
Cash generated from operations 37 280,622 176,999
Financial expenses paid (18,827) (6,404)
Taxes paid (73,582) (113,353)
Payment of gratuity (5,034) (4,659
Increase in long-term loans (1,886)
Decrease in long-term deposit and prepayments 680 219
---------- ----------
Net cash inflow from operating activities 181,973 50,894
CASH FLOW FROM INVESTING ACTIVITIES ---------- ----------
Fixed capital expenditure (57,222) (126,282
Sale proceeds of fixed assets 2,439 2,463
Interest received 35,250 23,060
Payment on account of - -
- Goodwill - (15,000)
- Deferred cost - (30,000)
---------- ----------
Net cash outflow from investing activities (19,533) (145,759)
CASH FLOW FROM FINANCING ACTIVITIES ---------- ----------
Dividend paid (105,5281 (93,019)
Repayment of long term loans (7661 -
---------- ----------
Net cash outflow from financing activities (106,294) (93,019)
---------- ----------
Net increase/(decrease) in cash and cash equivalents 56,146 (187,884)
Cash and cash equivalents at the beginning of the year (39,394) 148,490
---------- ----------
Cash and cash equivalents at the end of the year 38 16,752 (39,394)
========== ==========
The annexed notes form an integral part of these accounts.
NOTES TO THE ACCOUNTS FOR THE 52 WEEKS ENDED JANUARY 3, 1998
L STATUS AND NATURE OF BUSINESS
The Company is incorporated in Pakistan and its shares are quoted on the Karachi and Lahore Stock